JP2002082046A - Urinalysis device - Google Patents

Urinalysis device

Info

Publication number
JP2002082046A
JP2002082046A JP2000272802A JP2000272802A JP2002082046A JP 2002082046 A JP2002082046 A JP 2002082046A JP 2000272802 A JP2000272802 A JP 2000272802A JP 2000272802 A JP2000272802 A JP 2000272802A JP 2002082046 A JP2002082046 A JP 2002082046A
Authority
JP
Japan
Prior art keywords
urine
light
wavelength
magnetic field
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000272802A
Other languages
Japanese (ja)
Other versions
JP4507372B2 (en
Inventor
Tadashi Miki
匡 三木
Hirohisa Imai
博久 今井
Sanenori Ueda
実紀 上田
Hisaaki Miyaji
寿明 宮地
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Priority to JP2000272802A priority Critical patent/JP4507372B2/en
Publication of JP2002082046A publication Critical patent/JP2002082046A/en
Application granted granted Critical
Publication of JP4507372B2 publication Critical patent/JP4507372B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a maintenance-free toilet seat having a urinalysis function with high measuring accuracy, without requiring an urine conveying mechanism, such as a pump. SOLUTION: A light emitting means 51 and a light receiving means 52 are sealed inside a nozzle 5 provided with a urine reservoir 55 and the concentration of urine sugar or urine proteins can be measured from changes in quantity of light coming from the light emitting means 51 and passing through the urine reservoir 55 and impinging on the light receiving portion 52, while reducing the influence of interfering substances.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は家庭や職場等におい
て簡便に健康管理が出来るように、尿糖など尿成分のチ
ェックを行う尿検査装置に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a urine testing apparatus for checking urine components such as urine sugar so that health can be easily managed at home or at work.

【0002】[0002]

【従来の技術】糖尿病などの予防や体調の管理などのた
めに、尿糖量や尿蛋白などの尿成分の検査に対する要望
が高まってきている。
2. Description of the Related Art There is an increasing demand for testing urine components such as urinary glucose and urine protein for prevention of diabetes and the management of physical condition.

【0003】従来の家庭で行う尿検査の方法としては、
これに薬局などで購入した尿試験紙を一定時間浸して試
験紙の化学反応による色の変化を読み取るというものが
中心であった。
[0003] Conventional methods for urinalysis at home include:
Mostly, a urine test paper purchased at a pharmacy or the like was immersed for a certain period of time, and the color change due to the chemical reaction of the test paper was read.

【0004】こうした方式に加えて、光の旋光度による
尿中の旋光物質の濃度計測を行う方式が提案されてい
る。この方式では、尿にレーザ光を照射した際に、尿中
の旋光物質濃度に応じて発生する旋光を、コイルに加え
る電流量に比例した磁場を印加することにより逆旋光を
起こさせてキャンセルするものであり、丁度両者の旋光
が同じになる時点の電流量から尿中の旋光物質濃度が算
出できうるものである。
In addition to such a method, a method has been proposed in which the concentration of a rotatory substance in urine is measured based on the optical rotation of light. In this method, when the urine is irradiated with a laser beam, the optical rotation generated according to the concentration of the optical rotation substance in the urine is reversed by applying a magnetic field proportional to the amount of current applied to the coil, thereby canceling the optical rotation. That is, the concentration of the optical rotation substance in urine can be calculated from the amount of current at the time when the optical rotations of the two become exactly the same.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、旋光方
式では、尿中の計測したい目的成分以外の旋光成分(以
下、妨害成分)によっても旋光が発生するため、妨害成
分が尿中に高濃度に存在する場合には、計測結果にズレ
が生じる場合があった。また、旋光方式は、多数回の計
測を行う間に付着した尿垢などによりレーザ光の透過量
が低下し、計測精度に影響が出る場合があった。
However, in the optical rotation method, optical rotation is also caused by the optical rotation component (hereinafter, interference component) other than the target component to be measured in urine, so that the interference component is present in high concentration in urine. In some cases, the measurement results may be shifted. In addition, in the optical rotation method, the amount of transmission of laser light is reduced due to scales or the like adhered during a large number of measurements, which may affect the measurement accuracy.

【0006】[0006]

【課題を解決するための手段】本発明では、掛かる課題
を鑑み、尿成分の旋光度から成分濃度を計測する装置に
おいて、第1波長および第2波長のそれぞれについて、
磁場印加手段により複数の磁場強度と前記複数の磁場強
度に応じて前記受光手段で受光した光強度から尿中の目
的成分濃度と妨害成分による旋光度の合算値を計測し、
予め設定した前記第1波長および第2波長における目的
成分と妨害成分の旋光度比率を使って前記第1波長およ
び第2波長で計測した旋光度から前記目的成分濃度を算
出している。
SUMMARY OF THE INVENTION In view of the above-mentioned problems, the present invention provides an apparatus for measuring the concentration of a component from the optical rotation of a urine component.
The combined value of the optical rotations due to the concentration of the target component in urine and the interfering component is measured from the light intensity received by the light receiving unit according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field application unit,
The concentration of the target component is calculated from the optical rotation measured at the first wavelength and the second wavelength using a preset optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength.

【0007】[0007]

【発明の実施の形態】請求項1に記載した発明は、第1
波長および第2波長の特定偏光方向の成分の光を発光す
る発光手段と、前記発光手段からの光に磁場を印加する
磁場印加手段と、前記発光手段から尿および磁場印加手
段を通過した光の特定偏光方向の成分を受光する受光手
段とを有し、前記第1波長および第2波長のそれぞれに
ついて、前記磁場印加手段により複数の磁場強度と前記
複数の磁場強度に応じて前記受光手段で受光した光強度
から尿中の目的成分濃度と妨害成分による旋光度の合算
値を計測し、予め設定した前記第1波長および第2波長
における目的成分と妨害成分の旋光度比率を使って前記
第1波長および第2波長で計測した旋光度から前記目的
成分濃度を算出する構成としている。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The first aspect of the present invention is a first aspect of the invention.
A light emitting unit that emits light of a component having a specific polarization direction of the wavelength and the second wavelength, a magnetic field applying unit that applies a magnetic field to the light from the light emitting unit, and a light passing through the urine and the magnetic field applying unit from the light emitting unit. A light receiving unit for receiving a component in a specific polarization direction, wherein for each of the first wavelength and the second wavelength, a plurality of magnetic field strengths are received by the magnetic field applying unit and the light is received by the light receiving unit in accordance with the plurality of magnetic field strengths From the obtained light intensity, the sum of the optical rotation due to the concentration of the target component in urine and the interfering component is measured, and the first optical rotation ratio between the target component and the interfering component at the first wavelength and the second wavelength is set in advance. The target component concentration is calculated from the optical rotation measured at the wavelength and the second wavelength.

【0008】請求項2に記載した発明は、尿を受けるノ
ズル内に、凹状に成形された尿溜り部と、第1波長およ
び第2波長の特定偏光方向の成分の光を発光する2組の
発光手段と、前記発光手段からの光に磁場を印加する磁
場印加手段と、前記発光手段から尿および磁場印加手段
を通過した光の特定偏光方向の成分を受光する2組の受
光手段とを有し、前記磁場印加手段により複数の磁場強
度と前記複数の磁場強度に応じて前記受光手段で受光し
た光強度から尿中の目的成分濃度と妨害成分による旋光
度の合算値を計測し、予め設定した前記第1波長および
第2波長における目的成分と妨害成分の旋光度比率を使
って前記第1波長および第2波長で計測した旋光度から
前記目的成分濃度を算出する構成としている。
According to a second aspect of the present invention, in a nozzle for receiving urine, a urine reservoir formed in a concave shape and two sets of light emitting components of a first polarization and a second wavelength in a specific polarization direction. A light-emitting means; a magnetic field applying means for applying a magnetic field to the light from the light-emitting means; and two sets of light-receiving means for receiving from the light-emitting means the urine and the component of the light having passed through the magnetic field applying means in a specific polarization direction. Then, the combined value of the optical rotations due to the concentration of the target component in urine and the interference component is measured from the plurality of magnetic field intensities by the magnetic field applying unit and the light intensity received by the light receiving unit in accordance with the plurality of magnetic field intensities, and preset. The target component concentration is calculated from the optical rotation measured at the first wavelength and the second wavelength using the optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength.

【0009】請求項3に記載した発明は、尿を受けるノ
ズル内に、凹状に成形された尿溜り部と、第1波長およ
び第2波長の特定偏光方向の成分の光を発光する2組の
発光手段と、前記発光手段からの光に磁場を印加する磁
場印加手段と、前記発光手段から尿および磁場印加手段
を通過した光の特定偏光方向の成分を受光する受光手段
とを有し、前記磁場印加手段により複数の磁場強度と前
記複数の磁場強度に応じて前記受光手段で受光した光強
度から尿中の目的成分濃度と妨害成分による旋光度の合
算値を計測し、予め設定した前記第1波長および第2波
長における目的成分と妨害成分の旋光度比率を使って前
記第1波長および第2波長で計測した旋光度から前記目
的成分濃度を算出する構成としている。
According to a third aspect of the present invention, in a nozzle for receiving urine, a urine reservoir formed in a concave shape and two sets of light emitting components having a first polarization and a second wavelength in a specific polarization direction. A light emitting unit, a magnetic field applying unit that applies a magnetic field to light from the light emitting unit, and a light receiving unit that receives a component in a specific polarization direction of light that has passed through the urine and the magnetic field applying unit from the light emitting unit, The combined value of the optical rotation due to the concentration of the target component in urine and the interfering component is measured from the light intensity received by the light receiving unit according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field application unit, and The target component concentration is calculated from the optical rotation measured at the first wavelength and the second wavelength using the optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength.

【0010】請求項4に記載した発明は、尿を受けるノ
ズル内に、尿を受ける凹状に成形され端面に反射材を配
置した尿溜り部と、第1波長および第2波長の特定偏光
方向の成分の光を発光する2組の発光手段と、前記発光
手段からの光に磁場を印加する磁場印加手段と、前記発
光手段から前記反射材で反射され尿および磁場印加手段
を通過した光の特定偏光方向の成分を受光する2組の受
光手段とを有し、前記磁場印加手段により複数の磁場強
度と前記複数の磁場強度に応じて前記受光手段で受光し
た光強度から尿中の目的成分濃度と妨害成分による旋光
度の合算値を計測し、予め決めておいた前記第1波長お
よび第2波長における目的成分と妨害成分の旋光度比率
を使って前記第1波長および第2波長で計測した旋光度
から前記目的成分濃度を算出する構成としている。
According to a fourth aspect of the present invention, there is provided a urine reservoir having a urine receiving portion formed in a concave shape for receiving urine and having a reflective material disposed on an end face thereof, in a nozzle for receiving urine, and a specific polarization direction of the first wavelength and the second wavelength. Two sets of light emitting means for emitting component light, a magnetic field applying means for applying a magnetic field to the light from the light emitting means, and identification of light reflected by the reflecting material from the light emitting means and passing through urine and the magnetic field applying means Two sets of light receiving means for receiving a component in a polarization direction, a plurality of magnetic field intensities by the magnetic field applying means, and a target component concentration in urine from light intensity received by the light receiving means in accordance with the plurality of magnetic field intensities. And the sum of the optical rotations due to the interfering component was measured, and measured at the first wavelength and the second wavelength using the predetermined optical rotation ratio of the target component and the interfering component at the first wavelength and the second wavelength. From the optical rotation, the target component It is configured to calculate the degree.

【0011】請求項5に記載した発明は、尿を受けるノ
ズル内に、凹状に成形され端面に反射材を配置した尿溜
り部と、第1波長および第2波長の特定偏光方向の成分
の光を発光する2組の発光手段と、前記発光手段からの
光に磁場を印加する磁場印加手段と、前記発光手段から
前記反射材で反射され尿および磁場印加手段を通過した
光の特定偏光方向の成分を受光する受光手段とを有し、
前記磁場印加手段により複数の磁場強度と前記複数の磁
場強度に応じて前記受光手段で受光した光強度から尿中
の目的成分濃度と妨害成分による旋光度の合算値を計測
し、予め決めておいた前記第1波長および第2波長にお
ける目的成分と妨害成分の旋光度比率を使って前記第1
波長および第2波長で計測した旋光度から前記目的成分
濃度を算出する構成としている。
According to a fifth aspect of the present invention, in a nozzle for receiving urine, a urine reservoir formed in a concave shape and having a reflective material disposed on an end face thereof, and light having a specific polarization direction of the first wavelength and the second wavelength. Two sets of light emitting means for emitting light, a magnetic field applying means for applying a magnetic field to light from the light emitting means, and a specific polarization direction of light reflected by the reflector from the light emitting means and passing through urine and the magnetic field applying means Light receiving means for receiving the component,
The sum of the optical rotations due to the concentration of the target component in urine and the interfering component is measured from the plurality of magnetic field intensities by the magnetic field applying unit and the light intensity received by the light receiving unit in accordance with the plurality of magnetic field intensities, and is determined in advance. Using the optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength,
The target component concentration is calculated from the optical rotation measured at the wavelength and the second wavelength.

【0012】請求項6に記載した発明は、目的成分と妨
害成分の旋光度比率を、尿の旋光を起こす主要物質とし
て、尿糖と尿蛋白との旋光度比率とする構成としてい
る。
The invention according to claim 6 is configured such that the optical rotation ratio between the target component and the interfering component is defined as the optical rotation ratio between urine sugar and urine protein as the main substance causing the rotation of urine.

【0013】請求項7に記載した発明は、目的成分と妨
害成分の旋光度比率を、尿糖と、他の尿中旋光物質の旋
光度を平均的な排出濃度比で過重平均した旋光度との旋
光度比率とする構成としている。
According to the present invention, the optical rotation ratio of the target component and the interfering component is determined by overaveraging the optical rotation ratio of urine sugar and other urinary optical rotation substances by an average discharge concentration ratio. The optical rotation ratio is set to.

【0014】請求項8に記載した発明は、他の尿中旋光
物質の旋光度を平均的な排出濃度比で過重平均した旋光
度を、年齢や性別などに応じて変更する構成としてい
る。
[0014] The invention described in claim 8 is configured so that the optical rotation obtained by overaveraging the optical rotation of other urinary optical rotation substances with an average discharge concentration ratio is changed according to age, sex, and the like.

【0015】請求項9に記載した発明は、2組の受光手
段または2組の発光手段をそれぞれ地面に対して水平方
向に配置する事により、2波長の光路間に重力による成
分濃度のムラがでないようにする構成としている。
According to the ninth aspect of the present invention, by disposing two sets of light receiving means or two sets of light emitting means in the horizontal direction with respect to the ground, unevenness of the component concentration due to gravity is caused between the two wavelength optical paths. It is configured not to be.

【0016】[0016]

【実施例】(実施例1)以下、本発明の実施例1につい
て図面を参照しながら説明する。図1は本一実施例の構
成を示すブロック図である。図1に示す温水洗浄便座
は、便座1や洗浄ノズルや制御回路などを格納する便座
ユニット部2から構成する。4は便器、3は洗浄水タン
クである。5は尿検査ノズルであり、便座ユニット部2
に尿検査ノズル5の回転や収納を行うギアモータなどか
らなるノズル駆動部を構成する。図1の尿検査ノズル5
の先端部の拡大図は、尿検査ノズルを反射タイプで構成
する場合を示し、51は発光部、52は受光部、55は
ノズルに掛けられた尿を溜める尿溜り部であり、551
は発光部51からのレーザ光を反射させて受光部52に
入射させる反射材である。
(Embodiment 1) Hereinafter, Embodiment 1 of the present invention will be described with reference to the drawings. FIG. 1 is a block diagram showing the configuration of this embodiment. The hot water flush toilet seat shown in FIG. 1 includes a toilet seat unit 2 that stores a toilet seat 1, a cleaning nozzle, a control circuit, and the like. 4 is a toilet bowl and 3 is a washing water tank. Reference numeral 5 denotes a urine test nozzle, which is a toilet seat unit 2
A nozzle driving unit including a gear motor for rotating and storing the urine test nozzle 5 is formed. Urine test nozzle 5 of FIG.
The enlarged view of the tip portion of the figure shows a case where the urine test nozzle is configured as a reflection type, where 51 is a light emitting unit, 52 is a light receiving unit, 55 is a urine reservoir that collects urine hung on the nozzle, and 551
Is a reflector that reflects the laser light from the light emitting unit 51 and makes it incident on the light receiving unit 52.

【0017】図3にこの尿検査ノズル5の先端部の構成
例を示す。図3の(a)は尿検査ノズル5の上面図、
(b)は側面図である。発光部51内の511は第1の
波長を発光するレーザ光源、512は第2の波長を発光
するレーザ光源、513は両レーザ光源から特定方向の
直線偏光成分のみを通過させる偏光フィルタである。ま
た、受光部52内の522は反射材53で反射されたレ
ーザ光に磁場を印加させるファラデーコイルであり、コ
イル芯部分には、水などの液状旋光材をガラスで封入す
るか、ガラスなどの固形旋光材を挿入する。523は、
発光部51から反射材53で反射され、ファラデーコイ
ル522を通過した光の内の特定方向の直線偏光成分を
通過させる検光フィルタであり、ここでは偏光フィルタ
と相対的に直交する方向に配置する。521は、検光フ
ィルタ523を通過した光量を検出する受光素子であ
る。なお、ファラデーコイル522は、発光部51側に
配置しても構わないものである。
FIG. 3 shows an example of the configuration of the tip of the urine test nozzle 5. FIG. 3A is a top view of the urine test nozzle 5,
(B) is a side view. Reference numeral 511 in the light emitting unit 51 denotes a laser light source that emits a first wavelength, 512 denotes a laser light source that emits a second wavelength, and 513 denotes a polarization filter that passes only linearly polarized light components in a specific direction from both laser light sources. A Faraday coil 522 in the light receiving section 52 applies a magnetic field to the laser beam reflected by the reflector 53. A liquid optical rotatory material such as water is sealed in the core of the coil with glass or a glass rotator. Insert the solid optical rotation material. 523 is
This is an analysis filter that passes a linearly polarized light component in a specific direction in the light reflected by the reflector 53 from the light emitting unit 51 and passing through the Faraday coil 522, and is disposed in a direction relatively orthogonal to the polarization filter here. . A light receiving element 521 detects the amount of light that has passed through the light analysis filter 523. Note that the Faraday coil 522 may be disposed on the light emitting unit 51 side.

【0018】図4は、図3に示す尿検査ノズル5の構成
で、尿糖値を算出する場合の制御ブロック図を示してい
る。図2の20は尿成分検査装置全体を制御する制御部
であり、マイコンおよびその周辺回路で構成する。21
はユーザが動作開始を指示する操作キーや尿検査の結果
を表示する液晶パネルなどから構成した入出力部、23
はレーザ光源511と512を交互に点灯や消灯を行う
発光回路、24は受光部521からの光量に応じた出力
信号を電圧値として制御部20に入力する光量検出回
路、25は522の電流量を調整して印加する磁場強度
や変調成分をコントロールする磁場印回路である。
FIG. 4 is a control block diagram when the urine sugar value is calculated with the configuration of the urine test nozzle 5 shown in FIG. Reference numeral 20 in FIG. 2 denotes a control unit for controlling the entire urine component testing apparatus, which is constituted by a microcomputer and its peripheral circuits. 21
23, an input / output unit composed of operation keys for instructing the user to start an operation and a liquid crystal panel for displaying a urine test result;
Is a light emitting circuit for turning on and off the laser light sources 511 and 512 alternately, 24 is a light quantity detecting circuit for inputting an output signal corresponding to the light quantity from the light receiving section 521 to the control section 20 as a voltage value, and 25 is a current quantity of 522 Is a magnetic field marking circuit for controlling the intensity of the applied magnetic field and the modulation component.

【0019】まず、ユーザが入出力部21より「検尿準
備」を指示すると、制御部20はノズル駆動部6により
格納していた尿検査ノズル5を便器4に突出させる。ユ
ーザが排尿を終えて、入出力部21より「検査開始」を
指示すると、制御部20は発光回路23により第1の波
長のレーザ光源511を点灯する。レーザ光源511か
ら光は尿溜まり55内の尿の尿糖濃度に応じて旋光さ
れ、検光子522を通過して受光素子521に入射す
る。入射された光量は、光量検出回路24により電圧に
変換されて制御部20に検出される。
First, when the user instructs “preparation for urine test” from the input / output unit 21, the control unit 20 causes the urine test nozzle 5 stored by the nozzle drive unit 6 to protrude into the toilet 4. When the user has finished urinating and instructs “test start” from the input / output unit 21, the control unit 20 turns on the laser light source 511 of the first wavelength by the light emitting circuit 23. The light from the laser light source 511 is rotated according to the urine sugar concentration of the urine in the urine reservoir 55, passes through the analyzer 522, and enters the light receiving element 521. The incident light amount is converted into a voltage by the light amount detection circuit 24 and detected by the control unit 20.

【0020】制御部20では、磁場印加回路25により
522ファラデーコイル523に流す電流を順次変化さ
せて印可する磁界強度を変え、受光素子512への入射
光量が最小になる時点のファラデーコイル522への電
流値を検出する。制御部20では、この電流値から予め
記憶させた計算プログラムに従って、電流値から第1の
波長λ1での旋光角度Θ1を算出する。
In the control unit 20, the current applied to the 522 Faraday coil 523 is sequentially changed by the magnetic field application circuit 25 to change the intensity of the applied magnetic field. Detect the current value. The control unit 20 calculates the optical rotation angle Θ1 at the first wavelength λ1 from the current value according to a calculation program stored in advance from the current value.

【0021】続いて、制御部20は、第2の波長のレー
ザ光源512を点灯して、第1の波長の場合と同様にし
て、第2の波長λ2での旋光角度Θ2を計測する。制御
部2は、この両旋光度Θ1、Θ2から妨害物質の影響を
補正した尿糖値を算出して、入出力部21により結果を
表示するものである。
Subsequently, the control unit 20 turns on the laser light source 512 of the second wavelength and measures the optical rotation angle Θ2 at the second wavelength λ2 in the same manner as in the case of the first wavelength. The control unit 2 calculates a urinary sugar value in which the influence of the interfering substance has been corrected from the optical rotations # 1 and # 2, and displays the result via the input / output unit 21.

【0022】以下、本実施例で旋光度Θ1、Θ2から尿
糖濃度を算出する場合の方法例を説明する。
Hereinafter, an example of a method for calculating the urine sugar concentration from the optical rotations # 1 and # 2 in this embodiment will be described.

【0023】一般には、計測される旋光角度Θは、単位
光路長かつ単位濃度当たりの旋光係数をαとし、尿中の
尿糖濃度をC、尿溜りセル55を光が反射して通過する
光路長を2Lとすると、(式1)となる。
In general, the measured optical rotation angle 、 is α, the optical rotation coefficient per unit optical path length and unit concentration is α, the urine sugar concentration in urine is C, and the optical path through which the light is reflected and passes through the urine storage cell 55. If the length is 2L, (Equation 1) is obtained.

【0024】Θ=α・C・2L (式1) しかし、これに蛋白質などの妨害成分が混入していた場
合には、計測される旋光角度Θは、妨害物質の単位光路
長かつ単位濃度当たりの旋光係数をα’とし、尿中の濃
度をC’とすると、(式2)のようになる。
Θ = α · C · 2L (Equation 1) However, in the case where an interfering component such as a protein is mixed therein, the measured optical rotation angle Θ is determined per unit optical path length and unit concentration of the interfering substance. If the optical rotation coefficient of α is α ′ and the concentration in urine is C ′, the following equation (2) is obtained.

【0025】 Θ=α・C・2L+α’・C’+2L (式2) これらの旋光係数は、波長特性を持っていることが知ら
れており、この定性的な関係を図2に示す。図2は、横
軸に波長、縦軸に単位光路長かつ単位濃度当たりの旋光
係数を採った糖およびの波長特性であり、81および8
2は、糖および妨害物質の波長特性である。プラス、マ
イナスは旋光する方向が逆である事を意味している。
Θ = α · C · 2L + α ′ · C ′ + 2L (Equation 2) It is known that these optical rotation coefficients have wavelength characteristics, and this qualitative relationship is shown in FIG. FIG. 2 shows the wavelength characteristics of sugar and 81 whose wavelength is taken on the horizontal axis and whose optical rotation coefficient per unit concentration and unit optical path length is taken on the vertical axis.
2 is the wavelength characteristic of the sugar and the interfering substance. Plus and minus mean that the direction of optical rotation is opposite.

【0026】いま、図4の構成で測定した第1の波長λ
1と第2の波長λ2の尿糖および妨害物質の旋光係数は
それぞれ、α11、−α21とα12とーα22である
から、これから(式2)に当てはめれば(式3)(式
4)のようになる。
Now, the first wavelength λ measured with the configuration of FIG.
Since the optical rotation coefficients of urine sugar and the interfering substance of the first and second wavelengths λ2 are α11, −α21, α12 and −α22, respectively, when applied to (Equation 2), (Equation 3) and (Equation 4) Become like

【0027】 Θ1=α11・C・2Lーα21・C’・2L (式3) Θ2=α12・C・2L−α22・C’・2L (式4) 以上より、図4の制御部20では、α11などの旋光係
数と尿溜りセル50の光路長を既知の定数として(式
3)(式4)から尿糖濃度Cを算出するプログラムを記
憶しておき、先に測定した第1及び第2の波長での旋光
角度Θ1、Θ2から尿糖濃度Cを算出するものである。
Θ1 = α11 · C · 2L−α21 · C ′ · 2L (Formula 3) Θ2 = α12 · C · 2L−α22 · C ′ · 2L (Formula 4) From the above, in the control unit 20 of FIG. A program for calculating the urine sugar concentration C from (Equation 3) and (Equation 4) using the optical rotation coefficient such as α11 and the optical path length of the urine collecting cell 50 as a known constant is stored, and the first and second measured values are measured. Is calculated from the optical rotation angles か ら 1 and Θ2 at the wavelength of.

【0028】なお、本実施例では、2つレーザ光源から
のレーザ光を1つの受光素子で受ける構成を示したが、
図5に示すような反射型の2レーザ光源2受光素子の
他、図6及び図7に示すような、透過型の構成も可能な
ものである。
In this embodiment, the configuration has been described in which laser light from two laser light sources is received by one light receiving element.
In addition to the reflection type two laser light source 2 light receiving element as shown in FIG. 5, a transmission type structure as shown in FIGS. 6 and 7 is also possible.

【0029】さらに、尿セル部50は、長期間の使用に
より、尿垢の付着などが考えられるため、着脱可能で交
換や掃除ができる構成にしておくことは非常に有効であ
る。
In addition, since the urine cell unit 50 may adhere to scale, etc., due to long-term use, it is very effective to make the urine cell unit 50 detachable and replaceable or cleaned.

【0030】また、2組の受光手段および2組の発光手
段をそれぞれ地面に対して水平方向に配置することによ
り、沈殿などによる2波長の光の光路上の成分ばらつき
を低減でき、尿糖値や尿蛋白質を精度高く測定できる。
By disposing the two sets of light receiving means and the two sets of light emitting means in the horizontal direction with respect to the ground, it is possible to reduce the variation in components on the optical path of light of two wavelengths due to sedimentation, etc. And urine protein can be measured with high accuracy.

【0031】(実施例2)以下、本発明の実施例2につ
いて図面を参照しながら説明する。本実施例では、装置
全体の構成や動作は第1の実施例と同様にできるもので
あり、第1および第2の波長で計測した旋光角度Θ1お
よびΘ2から尿糖濃度を算出する演算方法を異にするも
のである。
(Embodiment 2) Hereinafter, Embodiment 2 of the present invention will be described with reference to the drawings. In the present embodiment, the configuration and operation of the entire apparatus can be performed in the same manner as in the first embodiment, and a calculation method for calculating the urine sugar concentration from the optical rotation angles Θ1 and Θ2 measured at the first and second wavelengths is described. It is different.

【0032】一般的に、濃度比率の高い尿中の旋光物質
としては、蛋白質やアミノ酸など知られており、これら
の物質の平均的な尿中濃度は文献などに紹介されてい
る。
Generally, proteins and amino acids are known as urinary optical rotation substances having a high concentration ratio, and the average urinary concentration of these substances is introduced in literatures.

【0033】図8に尿糖値を計測する際の妨害成分の代
表成分として、尿蛋白質と尿アミノ酸の定性的な波長特
性を示している。今、平均的な尿中の尿蛋白質を尿アミ
ノ酸濃度比をRとする。尿中の成分濃度の変化の一因と
しては、発汗や飲料などの尿量差による濃縮具合により
変動することが知られており、こうしたケースでは両者
の濃度はRに近い比率を保って変動することが考えられ
る。
FIG. 8 shows the qualitative wavelength characteristics of urine protein and urine amino acid as representative components of the interference components in measuring the urinary sugar level. Here, the average urine protein in urine is represented by a urine amino acid concentration ratio of R. It is known that one factor of the change in the concentration of the components in the urine varies depending on the degree of concentration due to the difference in the amount of urine such as perspiration or a drink. In such a case, the concentrations of both components fluctuate while maintaining a ratio close to R. It is possible.

【0034】従って、両者の平均的な濃度比率Rの荷重
平均を妨害物質の仮想的な旋光係数として利用すること
が可能である。
Therefore, it is possible to use the weighted average of the average concentration ratio R of the two as the virtual optical rotation coefficient of the interfering substance.

【0035】この場合のそれぞれ、 α21’=(α21+R・α31)/(R+1) α22’=(α22+R・α32)/(R+1) 従って、第1の実施例と同様に、制御部20はこのα2
1’とα22’を使って尿糖の濃度を算出し、入出力部
21に算出結果を表示するものである。
In this case, α21 ′ = (α21 + R · α31) / (R + 1) α22 ′ = (α22 + R · α32) / (R + 1) Therefore, as in the first embodiment, the control unit 20 sets the α2
The urine sugar concentration is calculated using 1 ′ and α22 ′, and the calculation result is displayed on the input / output unit 21.

【0036】なお、尿中物質の平均濃度は男女間や年齢
などでも異なることが知られており、例えば入出力部2
1から男女の区別などを入力する構成とし、最適な、α
21’やα22’を使って算出する方法も有効である。
It is known that the average concentration of the urine substance differs between men and women and the age.
It is configured to input gender distinction from 1 and the optimal α
A method of calculating using 21 ′ and α22 ′ is also effective.

【0037】[0037]

【発明の効果】請求項1に記載した発明は、第1波長お
よび第2波長で計測した旋光度から目的成分濃度を算出
することにより、妨害成分の影響の少ない精度の高い尿
検査装置を提供できるものである。
According to the first aspect of the present invention, there is provided a highly accurate urine test apparatus which calculates the concentration of a target component from the optical rotation measured at the first wavelength and the second wavelength, thereby reducing the influence of interference components. You can do it.

【0038】請求項2に記載した発明は、尿を受けるノ
ズル内に、凹状に成形された尿溜り部と、第1波長およ
び第2波長の特定偏光方向の成分のみの光を発光する2
組の発光手段と、前記発光手段からの光に磁場を印加す
る磁場印加手段と、前記発光手段から尿および磁場印加
手段を通過した光の特定偏光方向の成分のみを受光する
2組の受光手段とを有し、前記磁場印加手段により複数
の磁場強度と前記複数の磁場強度に応じて前記受光手段
で受光した光強度から尿中の目的成分濃度と妨害成分に
よる旋光度の合算値を計測し、予め決めておいた前記第
1波長および第2波長における目的成分と妨害成分の旋
光度比率を使って前記第1波長および第2波長で計測し
た旋光度から前記目的成分濃度を算出することにより、
妨害物質などの影響の少ない精度の高い温水洗浄便座な
どに取り付けのできる尿検査装置を提供できるものであ
る。
According to a second aspect of the present invention, in a nozzle for receiving urine, a urine reservoir formed in a concave shape, and emits only light having a specific polarization direction of the first wavelength and the second wavelength.
A set of light emitting means, a magnetic field applying means for applying a magnetic field to the light from the light emitting means, and two sets of light receiving means for receiving only components of light having passed through the urine and the magnetic field applying means from the light emitting means in a specific polarization direction And measuring the sum of the optical rotations due to the concentration of the target component in urine and the interference component from the light intensity received by the light receiving means according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field applying means. Calculating the concentration of the target component from the optical rotation measured at the first wavelength and the second wavelength using a predetermined optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength. ,
It is an object of the present invention to provide a urine testing apparatus that can be attached to a high-precision warm water flush toilet seat or the like that is less affected by interfering substances and the like.

【0039】請求項3に記載した発明は、請求項2に記
載の発明に加えて、第1波長および第2波長の特定偏光
方向の成分のみの光を発光する2組の発光手段からの光
を、1つの受光手段で受光するように構成することで、
構成部品の少ない温水洗浄便座などに取り付けのできる
尿検査装置を提供できるものである。
According to a third aspect of the present invention, in addition to the second aspect of the invention, light from two sets of light emitting means for emitting light of only the components of the first and second wavelengths in the specific polarization direction is provided. Is configured to be received by one light receiving unit,
It is possible to provide a urine test apparatus which can be attached to a warm water flush toilet seat having a small number of components.

【0040】請求項4に記載した発明は、尿を受けるノ
ズル内に、凹状に成形され端面に反射材を配置した尿溜
り部と、第1波長および第2波長の特定偏光方向の成分
のみの光を発光する2組の発光手段と、前記発光手段か
らの光に磁場を印加する磁場印加手段と、前記発光手段
から前記反射材で反射され尿および磁場印加手段を通過
した光の特定偏光方向の成分のみを受光する2組の受光
手段とを有し、前記磁場印加手段により複数の磁場強度
と前記複数の磁場強度に応じて前記受光手段で受光した
光強度から尿中の目的成分濃度と妨害成分による旋光度
の合算値を計測し、予め決めておいた前記第1波長およ
び第2波長における目的成分と妨害成分の旋光度比率を
使って前記第1波長および第2波長で計測した旋光度か
ら前記目的成分濃度を算出することにより、妨害物質な
どの影響の少ない精度の高く、尿溜り部の交換や掃除に
都合のよい構成を採ることができる温水洗浄便座などに
取り付けのできる尿検査装置を提供できるものである。
According to a fourth aspect of the present invention, there is provided a urine collecting portion having a concave shape and a reflective material disposed on an end face in a nozzle for receiving urine, comprising only a component in a specific polarization direction of the first wavelength and the second wavelength. Two sets of light emitting means for emitting light, a magnetic field applying means for applying a magnetic field to the light from the light emitting means, and a specific polarization direction of the light reflected by the reflector from the light emitting means and passing through the urine and the magnetic field applying means And a target component concentration in urine from the light intensity received by the light receiving means according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field applying means. Optical rotation measured at the first and second wavelengths by measuring the sum of the optical rotations due to the interfering component and using a predetermined optical rotation ratio between the target component and the interfering component at the first and second wavelengths. From the concentration of the target ingredient By calculating the above, it is possible to provide a urine testing apparatus that can be attached to a hot water flush toilet seat or the like that can adopt a configuration that is highly accurate with little influence of interfering substances and is convenient for exchanging and cleaning the urine reservoir. is there.

【0041】請求項5に記載した発明は、請求項4に記
載の発明に加えて、第1波長および第2波長の特定偏光
方向の成分のみの光を発光する2組の発光手段からの光
を、1つの受光手段で受光するように構成することで、
構成部品の少ない温水洗浄便座などに取り付けのできる
尿検査装置を提供できるものである。
According to a fifth aspect of the present invention, in addition to the fourth aspect of the present invention, light from two sets of light emitting means that emits only light having a specific polarization direction of the first wavelength and the second wavelength. Is configured to be received by one light receiving unit,
It is possible to provide a urine test apparatus which can be attached to a warm water flush toilet seat having a small number of components.

【0042】請求項6に記載の発明は、目的成分と妨害
成分の旋光度比率を、尿中での主要な旋光物質成分であ
る尿糖と尿蛋白質との旋光度比率を使って算出を行うこ
とにより、尿糖値や尿蛋白質を精度の高く測定できる温
水洗浄便座などに取り付けのできる尿検査装置を提供で
きるものである。
According to the sixth aspect of the present invention, the optical rotation ratio between the target component and the interfering component is calculated using the optical rotation ratio between urine sugar and urine protein, which are the main optical rotation components in urine. Accordingly, it is possible to provide a urine test apparatus which can be attached to a warm water flush toilet seat or the like which can measure urine sugar level and urine protein with high accuracy.

【0043】請求項7に記載の発明は、目的成分と妨害
成分の旋光度比率を、尿糖と、および他の尿中旋光物質
の旋光度を平均的な排出濃度比で過重平均した旋光度と
の旋光度比率とすることにより、他の旋光成分の影響も
提言できる更に精度の高く測定できる温水洗浄便座など
に取り付けのできる尿検査装置を提供できるものであ
る。
According to a seventh aspect of the present invention, the optical rotation ratio of the target component and the interfering component is obtained by overweighting the optical rotation ratio of urine sugar and other urinary optical rotation substances by an average discharge concentration ratio. By setting the optical rotation ratio to the above, it is possible to provide a urine test apparatus that can be attached to a warm water washing toilet seat or the like that can measure with higher accuracy that can also suggest the influence of other optical rotation components.

【0044】請求項8に記載の発明は、他の尿中旋光物
質の旋光度を平均的な排出濃度比で過重平均した旋光度
を、年齢や性別などに応じて変更する構成とすることに
より、個人差による妨害成分の影響をより低減でき、尿
糖値や尿蛋白質を精度の高く測定できる温水洗浄便座な
どに取り付けのできる尿検査装置を提供できるものであ
る。
The invention according to claim 8 is characterized in that the optical rotation obtained by overaveraging the optical rotation of other urinary optical rotation substances with an average discharge concentration ratio is changed according to age, sex, and the like. Also, it is possible to provide a urine test apparatus which can reduce the influence of interfering components due to individual differences and which can be attached to a warm water flush toilet seat or the like which can measure urine sugar level and urine protein with high accuracy.

【0045】請求項9に記載の発明は、2組の受光手段
および2組の発光手段をそれぞれ地面に対して水平方向
に配置することにより、沈殿などによる2波長の光の光
路上の成分ばらつきを低減でき、尿糖値や尿蛋白質を精
度高く測定できる温水洗浄便座などに取り付けのできる
尿検査装置を提供できるものである。
According to the ninth aspect of the present invention, two sets of light receiving means and two sets of light emitting means are respectively arranged in the horizontal direction with respect to the ground, so that component dispersion on the optical path of light of two wavelengths due to precipitation or the like. It is possible to provide a urine test apparatus which can be attached to a warm water flush toilet seat or the like which can measure urinary sugar level and urine protein with high accuracy.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の第1の実施例である温水洗浄便座に組
み込んだ尿検査装置構成図
FIG. 1 is a configuration diagram of a urine test apparatus incorporated in a warm water flush toilet seat according to a first embodiment of the present invention.

【図2】同尿成分の旋光度の定性特性示すグラフFIG. 2 is a graph showing qualitative characteristics of the optical rotation of the urine component.

【図3】(a)同尿検査ノズルの構成を示す上面図 (b)同側面図FIG. 3A is a top view showing the configuration of the urine test nozzle, and FIG.

【図4】同制御ブロックの一例を示すブロック図FIG. 4 is a block diagram showing an example of the control block.

【図5】(a)尿検査ノズルの構成を示す上面図 (b)同側面図FIG. 5A is a top view showing the configuration of a urine test nozzle, and FIG.

【図6】(a)同尿検査ノズルの他の構成を示す上面図 (b)同側面図FIG. 6A is a top view showing another configuration of the urine test nozzle, and FIG.

【図7】(a)同尿検査ノズルの構成を示す上面図 (b)同側面図FIG. 7A is a top view showing the configuration of the urine test nozzle, and FIG.

【図8】同代表妨害成分の定性特性を示すグラフFIG. 8 is a graph showing qualitative characteristics of the representative interference component.

【符号の説明】[Explanation of symbols]

5 尿検査ノズル 25 磁場印回路(磁場印加手段) 51 発光部(発光手段) 52 受光部(受光手段) 55 尿溜り部 551 反射材 522 ファラデーコイル(磁場印加手段) 5 Urine test nozzle 25 Magnetic field marking circuit (magnetic field applying means) 51 Light emitting unit (light emitting unit) 52 Light receiving unit (light receiving unit) 55 Urine reservoir 551 Reflector 522 Faraday coil (magnetic field applying unit)

───────────────────────────────────────────────────── フロントページの続き (72)発明者 上田 実紀 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 宮地 寿明 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 Fターム(参考) 2G045 AA16 AA36 CB03 DA31 FA11 GC30 JA01 2G059 AA01 BB13 CC16 DD12 EE01 EE05 EE11 GG01 GG04 JJ19 KK01 LL04 MM03 MM05 PP04 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Miki Ueda 1006 Kazuma Kadoma, Osaka Pref. Matsushita Electric Industrial Co., Ltd. (72) Inventor Toshiaki Miyachi 1006 Odaka Kadoma Kadoma, Osaka Pref. Terms (reference) 2G045 AA16 AA36 CB03 DA31 FA11 GC30 JA01 2G059 AA01 BB13 CC16 DD12 EE01 EE05 EE11 GG01 GG04 JJ19 KK01 LL04 MM03 MM05 PP04

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】 第1波長および第2波長の特定偏光方向
の成分のみの光を発光する発光手段と、前記発光手段か
らの光に磁場を印加する磁場印加手段と、前記発光手段
から尿および磁場印加手段を通過した光の特定偏光方向
の成分を受光する受光手段とを有し、前記第1波長およ
び第2波長のそれぞれについて、前記磁場印加手段によ
り複数の磁場強度と前記複数の磁場強度に応じて前記受
光手段で受光した光強度から尿中の目的成分濃度と妨害
成分による旋光度の合算値を計測し、予め設定した前記
第1波長および第2波長における目的成分と妨害成分の
旋光度比率を使って前記第1波長および第2波長で計測
した旋光度から前記目的成分濃度を算出する尿検査装
置。
1. A light emitting means for emitting light having only a component having a specific polarization direction of a first wavelength and a second wavelength; a magnetic field applying means for applying a magnetic field to light from the light emitting means; Light receiving means for receiving a component of light having passed through the magnetic field applying means in a specific polarization direction; and for each of the first wavelength and the second wavelength, a plurality of magnetic field strengths and a plurality of magnetic field strengths by the magnetic field applying means. In accordance with the above, the sum of the optical rotation due to the concentration of the target component in urine and the interfering component is measured from the light intensity received by the light receiving means, and the optical rotation of the target component and the interfering component at the preset first and second wavelengths is measured. A urine test apparatus for calculating the concentration of the target component from the optical rotation measured at the first wavelength and the second wavelength using a degree ratio.
【請求項2】 尿を受けるノズル内に凹状に成形された
尿溜り部と、第1波長および第2波長の特定偏光方向の
成分の光を発光する2組の発光手段と、前記発光手段か
らの光に磁場を印加する磁場印加手段と、前記発光手段
から尿および磁場印加手段を通過した光の特定偏光方向
の成分を受光する2組の受光手段とを有し、前記磁場印
加手段により複数の磁場強度と前記複数の磁場強度に応
じて前記受光手段で受光した光強度から尿中の目的成分
濃度と妨害成分による旋光度の合算値を計測し、前記第
1波長および第2波長における目的成分と妨害成分の旋
光度比率を使って前記第1波長および第2波長で計測し
た旋光度から前記目的成分濃度を算出する尿検査装置。
2. A urine reservoir formed in a concave shape in a nozzle for receiving urine, two sets of light emitting means for emitting light having a first polarization and a second wavelength in a specific polarization direction, and Magnetic field applying means for applying a magnetic field to the light, and two sets of light receiving means for receiving a component in a specific polarization direction of light passing through the urine and the magnetic field applying means from the light emitting means. The total value of the optical rotations due to the concentration of the target component in urine and the interfering component is measured from the light intensity received by the light receiving means according to the magnetic field strength of the plurality of magnetic fields and the plurality of magnetic field strengths. A urine test apparatus for calculating the concentration of the target component from the optical rotation measured at the first wavelength and the second wavelength using the optical rotation ratio of the component and the interfering component.
【請求項3】 尿を受けるノズル内に凹状に成形された
尿溜り部と、第1波長および第2波長の特定偏光方向の
成分の光を発光する2組の発光手段と、前記発光手段か
らの光に磁場を印加する磁場印加手段と、前記発光手段
から尿および磁場印加手段を通過した光の特定偏光方向
の成分を1組の受光する受光手段とを有し、前記磁場印
加手段により複数の磁場強度と前記複数の磁場強度に応
じて前記受光手段で受光した光強度から尿中の目的成分
濃度と妨害成分による旋光度の合算値を計測し、予め設
定した前記第1波長および第2波長における目的成分と
妨害成分の旋光度比率を使って前記第1波長および第2
波長で計測した旋光度から前記目的成分濃度を算出する
尿検査装置。
3. A urine reservoir formed in a concave shape in a nozzle for receiving urine, two sets of light emitting means for emitting light having a specific polarization direction of a first wavelength and a second wavelength, and two sets of light emitting means; Magnetic field applying means for applying a magnetic field to the light, and a set of light receiving means for receiving a component of a specific polarization direction of the light passing through the urine and the magnetic field applying means from the light emitting means. The total value of the optical rotation due to the concentration of the target component in urine and the interfering component is measured from the light intensity received by the light receiving means according to the magnetic field strength of the plurality of magnetic fields and the plurality of magnetic field strengths, and the first wavelength and the second wavelength set in advance are measured. The first wavelength and the second wavelength are determined by using the optical rotation ratio of the target component and the interference component at the wavelength.
A urine test apparatus for calculating the concentration of the target component from the optical rotation measured at a wavelength.
【請求項4】 尿を受けるノズル内凹状に成形され端面
に反射材を配置した尿溜り部と、第1波長および第2波
長の特定偏光方向の成分の光を発光する2組の発光手段
と、前記発光手段からの光に磁場を印加する磁場印加手
段と、前記発光手段から前記反射材で反射され尿および
磁場印加手段を通過した光の特定偏光方向の成分を受光
する2組の受光手段とを有し、前記磁場印加手段により
複数の磁場強度と前記複数の磁場強度に応じて前記受光
手段で受光した光強度から尿中の目的成分濃度と妨害成
分による旋光度の合算値を計測し、予め設定した前記第
1波長および第2波長における目的成分と妨害成分の旋
光度比率を使って前記第1波長および第2波長で計測し
た旋光度から前記目的成分濃度を算出する尿検査装置。
4. A urine reservoir formed in a concave shape in a nozzle for receiving urine and having a reflective material disposed on an end face thereof, and two sets of light emitting means for emitting light of a specific polarization direction of the first wavelength and the second wavelength. A magnetic field applying means for applying a magnetic field to the light from the light emitting means, and two sets of light receiving means for receiving a component of light having a specific polarization direction reflected from the light emitting means by the reflector and passing through the urine and the magnetic field applying means. And measuring the sum of the optical rotations due to the concentration of the target component in urine and the interference component from the light intensity received by the light receiving means according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field applying means. A urine test apparatus for calculating the concentration of the target component from the optical rotation measured at the first wavelength and the second wavelength using a preset optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength.
【請求項5】 尿を受けるノズル内に、凹状に成形され
端面に反射材を配置した尿溜り部と、第1波長および第
2波長の特定偏光方向の成分の光を発光する2組の発光
手段と、前記発光手段からの光に磁場を印加する磁場印
加手段と、前記発光手段から前記反射材で反射され尿お
よび磁場印加手段を通過した光の特定偏光方向の成分を
受光する1組の受光手段とを有し、前記磁場印加手段に
より複数の磁場強度と前記複数の磁場強度に応じて前記
受光手段で受光した光強度から尿中の目的成分濃度と妨
害成分による旋光度の合算値を計測し、予め設定した前
記第1波長および第2波長における目的成分と妨害成分
の旋光度比率を使って前記第1波長および第2波長で計
測した旋光度から前記目的成分濃度を算出する尿検査装
置。
5. A set of urine having a concave shape and a reflective material disposed on an end face thereof in a nozzle for receiving urine, and two sets of light emitting units for emitting light of components having a first polarization and a second wavelength in a specific polarization direction. Means, a magnetic field applying means for applying a magnetic field to the light from the light emitting means, and a set of light receiving a component of a specific polarization direction of the light reflected by the reflector from the light emitting means and passing through the urine and the magnetic field applying means. A light receiving means, and the combined value of the optical rotations due to the concentration of the target component in urine and the interference component from the light intensity received by the light receiving means according to the plurality of magnetic field strengths and the plurality of magnetic field strengths by the magnetic field applying means. Urine test which measures and calculates the concentration of the target component from the optical rotation measured at the first wavelength and the second wavelength using a preset optical rotation ratio of the target component and the interference component at the first wavelength and the second wavelength. apparatus.
【請求項6】 目的成分と妨害成分の旋光度比率を、尿
糖と、蛋白質との旋光度比率とする請求項1から5のい
ずれか1項に記載の尿検査装置。
6. The urine test apparatus according to claim 1, wherein the optical rotation ratio between the target component and the interfering component is the optical rotation ratio between urine sugar and the protein.
【請求項7】 目的成分と妨害成分の旋光度比率を、尿
糖と他の尿中旋光物質の旋光度を平均的な排出濃度比で
過重平均した旋光度との旋光度比率とする請求項1から
5のいずれか1項に記載の尿検査装置。
7. The method according to claim 1, wherein the optical rotation ratio between the target component and the interfering component is defined as an optical rotation ratio of the optical rotation of urine sugar and the other urinary optical rotation substance, which is a weighted average of the optical emission concentrations. The urine test apparatus according to any one of 1 to 5.
【請求項8】 他の尿中旋光物質の旋光度を平均的な排
出濃度比で過重平均した旋光度を、年齢や性別などに応
じて変更する請求項7記載の尿検査装置。
8. The urinalysis apparatus according to claim 7, wherein the optical rotation obtained by overaveraging the optical rotations of other urinary optical rotation substances with an average emission concentration ratio is changed according to age, sex, and the like.
【請求項9】 2組の受光手段または2組の発光手段を
それぞれ地面に対して水平方向に配置する請求項2、ま
たは4記載の尿検査装置。
9. The urine test apparatus according to claim 2, wherein two sets of light receiving means or two sets of light emitting means are respectively arranged in a horizontal direction with respect to the ground.
JP2000272802A 2000-09-08 2000-09-08 Urinalysis device Expired - Fee Related JP4507372B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000272802A JP4507372B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000272802A JP4507372B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Publications (2)

Publication Number Publication Date
JP2002082046A true JP2002082046A (en) 2002-03-22
JP4507372B2 JP4507372B2 (en) 2010-07-21

Family

ID=18758855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000272802A Expired - Fee Related JP4507372B2 (en) 2000-09-08 2000-09-08 Urinalysis device

Country Status (1)

Country Link
JP (1) JP4507372B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095988A1 (en) * 2002-05-08 2003-11-20 Arkray, Inc. Ingredient concentration measurement method and device
JPWO2005093410A1 (en) * 2004-03-29 2008-02-14 シチズンホールディングス株式会社 Optical measuring device
JP2011145284A (en) * 2009-12-18 2011-07-28 Horiba Ltd Polarimeter
WO2015141804A1 (en) * 2014-03-20 2015-09-24 富士ゼロックス株式会社 Optically active substance concentration calculation system, optically active substance concentration calculation system manufacturing method, computer-readable medium and program

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105699636B (en) * 2015-05-17 2018-01-05 青岛市妇女儿童医院 Medical urine analytical instrument

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510368A (en) * 1991-09-05 1994-11-17 ザ ダウ ケミカル カンパニー Fiber optic probe and method for detecting optically active materials
JPH0968523A (en) * 1995-08-31 1997-03-11 Brother Ind Ltd Biochemical substance measuring device
JPH09138231A (en) * 1995-11-16 1997-05-27 Matsushita Electric Ind Co Ltd Urinalytical method
JPH09281101A (en) * 1996-04-18 1997-10-31 Matsushita Electric Ind Co Ltd Equipment for urinalysis and discharging apparatus using the same
JP2000039361A (en) * 1998-07-22 2000-02-08 Jasco Corp Multi-wavelength polarimeter
JP2000214081A (en) * 1999-01-27 2000-08-04 Matsushita Electric Ind Co Ltd Measuring container and measuring apparatus for angle of rotation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510368A (en) * 1991-09-05 1994-11-17 ザ ダウ ケミカル カンパニー Fiber optic probe and method for detecting optically active materials
JPH0968523A (en) * 1995-08-31 1997-03-11 Brother Ind Ltd Biochemical substance measuring device
JPH09138231A (en) * 1995-11-16 1997-05-27 Matsushita Electric Ind Co Ltd Urinalytical method
JPH09281101A (en) * 1996-04-18 1997-10-31 Matsushita Electric Ind Co Ltd Equipment for urinalysis and discharging apparatus using the same
JP2000039361A (en) * 1998-07-22 2000-02-08 Jasco Corp Multi-wavelength polarimeter
JP2000214081A (en) * 1999-01-27 2000-08-04 Matsushita Electric Ind Co Ltd Measuring container and measuring apparatus for angle of rotation

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095988A1 (en) * 2002-05-08 2003-11-20 Arkray, Inc. Ingredient concentration measurement method and device
US7239904B2 (en) 2002-05-08 2007-07-03 Arkray, Inc. Component concentration measurement method and device
JP2010164570A (en) * 2002-05-08 2010-07-29 Arkray Inc Ingredient concentration measurement method
JP4717949B2 (en) * 2002-05-08 2011-07-06 アークレイ株式会社 Component concentration measurement method
JPWO2005093410A1 (en) * 2004-03-29 2008-02-14 シチズンホールディングス株式会社 Optical measuring device
JP4742031B2 (en) * 2004-03-29 2011-08-10 シチズンホールディングス株式会社 Optical measuring device
JP2011145284A (en) * 2009-12-18 2011-07-28 Horiba Ltd Polarimeter
WO2015141804A1 (en) * 2014-03-20 2015-09-24 富士ゼロックス株式会社 Optically active substance concentration calculation system, optically active substance concentration calculation system manufacturing method, computer-readable medium and program
US9851293B2 (en) 2014-03-20 2017-12-26 Fuji Xerox Co., Ltd. Concentration calculation system of optically active substance, manufacturing method of concentration calculation system of optically active substance, and computer readable medium

Also Published As

Publication number Publication date
JP4507372B2 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
AU761438B2 (en) Sample detection to initiate timing of an electrochemical assay
KR100540849B1 (en) A device for analyzing quantitatively material of a living creature
US5858799A (en) Surface plasmon resonance chemical electrode
WO1997018470A1 (en) Method and apparatus for urinalysis, method of measuring optical rotation and polarimeter
WO2009031761A1 (en) Biosensor and readout meter
JP2001515203A (en) Verifier for optical clinical assay systems
CN101308092B (en) Fluorescence spectrophotometer
US6747276B2 (en) Interference filter transmission wavelength scanning photometer
JP2002082046A (en) Urinalysis device
JPH0816649B2 (en) Liquid analysis calibration method
JP3308173B2 (en) Urine test method and urine test apparatus used therefor
JP2002228658A (en) Analyzer
JP2002082047A (en) Urinalysis device
US20060173636A1 (en) Apparatus and methods for simultaneous surface accoustic wave and surface plasmon resonance measurements
FI89412C (en) Method and polarimeter for measuring widening of the polarization plane in sugar or other solution
JP3236251B2 (en) How to measure specific component concentration
JP2006349556A (en) Surface plasmon sensor
RU2192632C1 (en) Procedure determining concentration of components in multicomponent solutions
JP2005265652A (en) Toilet seat
JP2007057317A (en) Automatic analyzer
WO2022128729A1 (en) System and method for signal calibration in a sensor system
WO2014137990A1 (en) IMPLEMENTATION OF A CALIBRATION-FREE ABSORBANCE SENSOR FOR MEASURING pH
David Johnson et al. Fluorescence methods for measuring calcium affinity and calcium exchange with proteins
JPH0634638A (en) Automatic chemical analyzer
JPS6318252A (en) Biochemical measuring apparatus

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070907

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20071012

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20091119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091208

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100413

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100426

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

R151 Written notification of patent or utility model registration

Ref document number: 4507372

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140514

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees